TABLE 3.
The benefits and limitations of different metabolism models.
| Models | Benefits | Limitations | |
|---|---|---|---|
| Primary enteric models | Microbiome-based model | Directly or indirectly affects drug metabolism | It is difficult to operate and requires the participation of animals |
| Cell-based enteric model | It mimicks well the environment of the intestine | It has difficult induce and culture process | |
| Primary Hepatic Models | Hepatocytes | It is currently the “gold standard” for in vitro drugs and xenobiotics metabolism experiments | It is difficult to simulate in vivo processes perfectly |
| Hepatocyte subcellular fractions | It is convenient and easy to prepare, has good reproducibility, easy storage of enzyme mixture and easy optimization of incubation conditions | It lacks a complete metabolic enzyme system | |
| Others | PCTS | It retains the activity of metabolic enzymes relatively intact, allowing the simultaneous analysis of multiple metabolites | It has high requirements on the operation of the experimenter |
| Isolated tissue perfusion system | It maintains the integrity of organs and cells, allowing experiments to be performed under near-physiological conditions | It takes a long time, and the segment tends to lose activity | |
| Gene recombinant enzymes | It is suitable for studying microscopic and detailed problems in the field of metabolism | The experiment cost is high, and the conditions are quite different from the internal environment | |
| Animals | It reflects the influence of phase I and phase II metabolic enzymes in living individuals | The experimental process is expensive, time-consuming, difficult to operate, has individual differences and ethical concerns | |